["{\n\"step_by_step_thinking\": \"The relevant documents provided do not contain information about the effectiveness of rt-PA (recombinant tissue plasminogen activator) based on the sex of acute stroke patients. The GISSI-2 trial and the International Study Group's study both analyzed the risk of stroke in patients with acute myocardial infarction treated with thrombolytic therapy, but they did not provide information about the effectiveness of rt-PA by sex. Therefore, we cannot determine whether the sex of acute stroke patients influences the effectiveness of rt-PA.\",\n\"answer_choice\": B\n}"]